Experiment 1324788

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

IBOGAINE,NOR:

Details

PropertyValue
Pharmacology
PHARMACOKINETIC STUDY OF
OrganismEmpty organism
CitationGLUE,P: CAPE,G: TUNNICLIFF,D: LOCKHART,M:LAM,F: HUNG,N: HUNG,CT: HARLAND,S: DEVANE,J:CROCKETT,RS: HOWES,J: DARPO,B: ZHOU,MJ: WEIS,H: FRIEDHOFF,L:. (2016). ASCENDING SINGLE-DOSE, DOUBLE-BLIND,PLACEBO-CONTROLLED SAFETY STUDY OFNORIBOGAINE IN OPIOID-DEPENDENT PATIENTS. 5(6)
Amount utilized
Compound isolated
DiseasePILOT STUDY TO EVALUATE THE SAFETY AND TOLERABILITY, PHARMACOKINETICS, AND PHAR-MACODYNAMICS OF SINGLE-DOSE NORIBOGAINE IN PATIENTS SEEKING TO DISCONTINUE METHADONE OPIOID SUBSTITUTION TREATMENT.
Dose amount3-60 MG
Number2
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE